News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 217–252
- Matches
- 21919
- Sources here
- 19
- Companies here
- 40
Active search
21919 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
HC Wainwright Analysts Increase Earnings Estimates for RIGL
HC Wainwright analysts have increased their Q3 2026 earnings per share estimate for Rigel Pharmaceuticals (NASDAQ:RIGL) to $0.99 from $0.68, maintaining a "Buy" rating and an $85 price target. This revision follows Rigel's strong quarterly results, where EPS of $0.88 significantly beat the $0.09 …
Regeneron ends eye disease study after antibody shows ‘unfavorable’ risk/benefit profile
Regeneron has terminated a Phase 1/2 study of its investigational anti-inflammatory antibody, REGN7041, for non-infectious uveitis due to an "unfavorable benefit-risk assessment." This marks another clinical setback for Regeneron, following failures of itepekimab for COPD and a melanoma combo. Despite these challenges, the company, …
Tesla Stock Remains ‘Highly Contentious’
It remains stuck as investors wait for the company’s AI business to take off. Shares haven’t done much (positive) for months as investors wait for AI progress. It is also preparing to build AI-trained humanoid robots, but investors haven’t seen the capabilities of Tesla’s …
Amer Sports, Inc. (AS) Beats Q2 Earnings and Revenue Estimates
Amer Sports, Inc. (AS) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.06 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents …
Q3 EPS Estimate for Vertical Aerospace Lifted by Analyst
HC Wainwright has revised its Q3 2026 EPS estimate for Vertical Aerospace (NYSE:EVTL) to a loss of $0.31 per share, an improvement from the previous forecast of a $0.43 loss. Despite this, the company reported a quarterly loss of $0.42 per share, missing the …
Q3 EPS Estimates for JAKKS Pacific Lowered by Zacks Research
Zacks Research has lowered its Q3 2026 EPS estimate for JAKKS Pacific (NASDAQ:JAKK) from $2.72 to $2.10, while maintaining a "Hold" rating on the stock. Despite this reduction, JAKKS Pacific recently reported strong Q2 earnings, surpassing analyst expectations with an EPS of $0.25 against …
We're Hopeful That First Tracks Biotherapeutics (NASDAQ:TRAX) Will Use Its Cash Wisely
First Tracks Biotherapeutics (NASDAQ:TRAX) has a cash runway of approximately 16 months, with US$168m in cash and a cash burn of US$124m. Despite being an early-stage company with no revenue, its cash burn rate is decreasing, and its ability to raise additional funds by …
AKR Upgraded by Keybanc -- Rating Changed to Overweight with $25 Price Target
Acadia Realty Trust (AKR) was upgraded to Overweight by Keybanc, with a new price target of $25.00, signaling increased confidence in the company's growth potential. Despite this positive analyst outlook, GuruFocus indicates AKR is currently 11.7% overvalued based on its GF Value™ of $18.64. …
Gildan Activewear Inc. (TSE:GIL) Plans Quarterly Dividend of $0.25
Gildan Activewear Inc. (TSE:GIL) has declared a quarterly dividend of C$0.249 per share, with an ex-dividend date of August 20th and payment scheduled for September 14th. The stock opened at C$77.53 and was down 1.5%, trading below its 200-day moving average. Analysts maintain a …
Abcuro Announces $66 Million Series D Financing to Advance Its First-In-Class Medicine in Development for Inclusion Body Myositis
Proceeds to support a potentially registrational clinical study in less severe inclusion body myositis (IBM) patients expected to begin in Q4 2026 and report top line results in 2H 2028 Ulviprubart showed a trend toward clinically meaningful slowing of disease progression in patients with …
4,700 Shares in Oracle Corporation $ORCL Acquired by Pingora Partners LLC
Pingora Partners LLC recently acquired 4,700 shares of Oracle Corporation, valued at approximately $689,000, adding to the 42.44% institutional ownership of the company. Despite a 2.5% decline in shares, Oracle reported strong quarterly earnings of $2.11 per share, exceeding estimates, and a 20.6% year-over-year …
Amylyx's experimental drug cut dangerous low-blood-sugar events by 55%
Amylyx Pharmaceuticals announced positive topline results from its Phase 3 LUCIDITY clinical trial for avexitide, an experimental drug for post-bariatric hypoglycemia (PBH). The trial showed a 55% reduction in severe hypoglycemic events compared to placebo, meeting its primary endpoint. Amylyx plans to submit a …
Amylyx’s bet on a GLP-1 blocker pays off
Amylyx Pharmaceuticals reported positive results from a late-stage clinical trial for avexitide, a GLP-1 blocker designed to treat dangerously low blood sugar levels in patients who have undergone bariatric surgery. The drug significantly reduced hypoglycemic events and appeared safe, leading Amylyx to plan for …
What's Going On With Oracle Stock Monday?
Oracle (ORCL) stock traded lower on Monday due to investor concerns about its aggressive AI infrastructure buildout and a short position taken by investor Michael Burry. Despite reports of a potential data center delay, Oracle confirmed its Project Jupiter is on schedule. The company …
11 Best New Cracker Barrel Fall Finds Flying Off Shelves Right Now
This article highlights 11 popular new fall products available at Cracker Barrel, ranging from home decor like pumpkin pillows and a unique horse side table, to seasonal items such as Christmas wall art, measuring cups, and candles. The author, Leah Groth, recommends these finds …
RXT Stock News: Rackspace Sued for Securities Fraud over Alleged Misrepresentations and Corresponding 33% Stock Drop
A securities fraud class action lawsuit has been filed against Rackspace Technology, Inc. (RXT) and its executives. The lawsuit alleges that Rackspace misled investors about its AI efforts and their financial impact, leading to a 33.6% stock drop on July 9, 2026, after the …
UNIVEST FINANCIAL Corp Takes Position in Vertex Pharmaceuticals Incorporated $VRTX
UNIVEST FINANCIAL Corp has acquired a new stake in Vertex Pharmaceuticals (NASDAQ:VRTX), purchasing 9,049 shares valued at approximately $4.495 million in the second quarter. This move is part of broader institutional investment activity in Vertex, which has seen numerous hedge funds and other institutional …
HONA Price Today: Honeywell Aerospace Inc. Stock Price, Quote & Chart | MEXC
This article provides a detailed overview of Honeywell Aerospace Inc. (HONA) stock, including its current trading price of $166.38, recent performance, and key market data such as market cap, open, high, low, and trading volume. It also explains how to buy HONA stock on …
Howmet Aerospace (NYSE:HWM) Combines High Growth Momentum with a Breakout Setup
Howmet Aerospace (NYSE:HWM) demonstrates strong growth momentum and a technical breakout setup, according to ChartMill's ratings. The company shows robust earnings and sales growth, consistent beats on EPS and revenue estimates, and positive analyst revisions, combined with a solid uptrend and price consolidation indicating …
UNIVEST FINANCIAL Corp Purchases Shares of 18,503 BlackRock $BLK
UNIVEST FINANCIAL Corp recently acquired 18,503 shares of BlackRock (NYSE:BLK) in the second quarter, making it their 22nd largest holding. Other institutional investors, including BlackRock Inc. and Corient Private Wealth LLC, also significantly increased their positions in the asset manager. BlackRock reported strong Q2 …
Occidental Asset Management LLC Invests $2.46 Million in Blackstone Inc. $BX
Occidental Asset Management LLC has invested $2.46 million in Blackstone Inc. during the second quarter, making them one of several institutional investors to hold a significant portion of BX shares. Blackstone has shown strong financial performance, exceeding analyst expectations with $1.52 in adjusted EPS …
Pallas Capital Advisors LLC Acquires New Position in West Pharmaceutical Services, Inc. $WST
Pallas Capital Advisors LLC has acquired a new stake in West Pharmaceutical Services, Inc. (NYSE:WST), purchasing 6,349 shares valued at approximately $2.28 million. This move comes as other institutional investors have also adjusted their positions in the medical instruments supplier, with several firms increasing …